The XANGEUS brand, founded in 2013 (France), from 306 sister brands and 4958 competing brands. The XANGEUS brand is owned by Ipsen, a company listed in Paris. The International Securities Identification Number (ISIN) of Ipsen is FR0010259150. XANGEUS belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Ipsen
(XANGEUS)
over 5 years*
EUR 122.43